Author:
Nakano Kiyotaka,Ishiguro Takahiro,Konishi Hiroko,Tanaka Megumi,Sugimoto Masamichi,Sugo Izumi,Igawa Tomoyuki,Tsunoda Hiroyuki,Kinoshita Yasuko,Habu Kiyoshi,Orita Tetsuro,Tsuchiya Masayuki,Hattori Kunihiro,Yamada-Okabe Hisafumi
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference37 articles.
1. Glypicans in growth control and cancer;Filmus;Glycobiology,2001
2. Mutations in GPC3, a glypican gene, cause the Simpson–Golabi–Behmel overgrowth syndrome;Pilia;Nat Genet,1996
3. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson–Golabi–Behmel syndrome;Cano-Gauci;J Cell Biol,1999
4. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling;Capurro;Cancer Res,2005
5. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution;Hsu;Cancer Res,1997
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献